Manage Your Liver

Liver cancer may still develop after successful DAA therapy, especially in patients with cirrhosis

Liver cancer may still develop after successful DAA therapy, especially in patients with cirrhosis

Since the introduction of direct-acting antiviral (DAA) therapy, treatment for hepatitis C (HCV) was revolutionized, as patient outcomes are improved with fewer side effects and high cure rate. However, there is significant debate in the society based on studies that suggest HCV cure does not eliminate risk for hepatocellular carcinoma (HCC) or liver cancer. Other research suggests the possibility of increased risk of developing liver cancer during and after DAA treatment in patients with hepatitis C.


Cirrhosis – a risk factor for liver cancer


A recent study presented at The Liver Meeting held by the American Association for the Study of Liver Diseases found patients with hepatitis C who take DAA medication are at an increased risk for more aggressive, infiltrative patterns of cancer, should they develop it.


Dr. Alberti, professor of gastroenterology at University of Padova in Italy, and his team recently looked at the incidence of new cases of liver cancer among HCV patients with advanced liver disease (such as cirrhosis) who were treated with DAAs. In different analyses of the data, Dr. Alberti’s team found elevated liver enzymes and low platelet count to be associated with liver cancer risk. The best baseline predictor of liver cancer risk was APRI scores, which calculate scarring or fibrosis in the liver. The researchers find the risk of developing liver cancer increased linearly by 10 per cent at each one-point increase in APRI value. This meant that cirrhotic patients with more severe fibrosis are at higher risk of liver cancer.


Risk of liver cancer remains even after DAA


“The results of this study indicate that there is no pharmacological prevention of HCC even with successful antiviral therapy, at least during the first six to 12 months after initiation of treatment,” Dr. Alberti stated.


Another study conducted by Dr. Thomas Baumert at the University of Strasbourg, France investigated the mechanism behind the development of HCC following HCV cure. They found that HCV infections produce changes in the liver that were only partially reversed by DAAs and that they persist after HCV cure. Both studies suggest liver cancer may still develop even after successful DAA treatment, as DAAs only remove the hepatitis C virus, while protection from liver cancer is not guaranteed.


Post-treatment monitoring of cirrhosis and care


In view of the above, it is essential that patients treated with DAAs with advanced liver disease like cirrhosis should continue to be monitored for HCC. Dr. Alberti’s team also recommended that those with compensated cirrhosis who have undergone successful DAA treatment should be monitored for liver cancer after 50 years of age. 


Apart from monitoring, post-treatment care for the liver is also necessary. As mentioned previously, DAAs only remove the hepatitis virus, but not the damage that has been done. Therefore, to prevent advancement of liver disease and liver cancer, we must first enhance the liver’s recovery ability and reverse fibrosis so that normal liver function is resumed.

  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
When someone went through hepatitis C treatment and achieved a successful SVR (sustained virologic response), it can be considered as cured. But liver protection and regular monitoring are still required depending on the condition of your liver at the time treatment ended. And here is why: For a starter, curing hepatitis C means that the viruses in the body is gone, and you can’t infect anyone else, but you could still get a new hepatitis C infection or other hepatit
The overall cancer death rate in the USA declined by 1.7 percent in 2015, this is the latest indication of steady, long-term progress against the disease, according to a new report by the American Cancer Society. However, look into the report in more detail we can see a continued increase of liver cancer cases, especially in women.   Over nearly a quarter-century, the mortality rate has fallen 26 percent, resulting in almost 2.4 million fewer deaths than if peak rates
Hit Questions
The liver carries out essential functions, including detoxifying harmful substances in your body, cleaning your blood and making new blood and other vital nutrients. Cirrhosis is scarring of the liver caused by long-term liver damage. The loss of liver cells turns into scar tissue which prevents the liver working normally, reducing or in some cases, completely losing liver function. Cirrhosis is a long-term chronic liver damage; it is often caused by chronic live
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
YHK Liver Therapy
Your Liver

starts here.
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us
Subscribe To Our Mailing List And
Never Miss Another Great Promotion!
Join our mailing list to receive latest new about our company, plus health articles. You will also be able to receive early bird discount from us!
Maybe Later, Thank you.
Subscribe success! You will receive latest new soon.